News 2024-12-06
Porton is thrilled to announce the launch of its newly redesigned official website
With a Focus on Globalization, Innovative Technology Platforms, and
Accelerating Your New Business Opportunities into the Clinic and to the Market.
The newly revamped website strategically highlights our commitment to a global service model, offering an enhanced customer experience through renewed and upgraded website features. This digital transformation aligns with Porton's mission of enabling the public’s early access to good medicines and underscores our dedication to providing comprehensive and innovative CDMO services. The redesigned site offers deep insights into Porton’s expanded range of Drug Substance and Drug Product services and innovative solutions, reinforcing Porton’s commitment to excellence and customer-centric focus on our global clientele.
The upgraded website, accessible at www.portonpharma.com, boasts a modern design and intuitive layout, making it easier for visitors to explore Porton’s portfolio of service offerings, site profiles, and technical solutions. We would like to discuss the key features of the new site with you.
Enhanced Navigation
A responsive and business driven design that provides seamless access across all devices, allowing users to find information quickly and efficiently.
This newly launched website embodies Porton's global vision and strategy, enabling users from all over the world to easily explore our new capabilities and services. This step towards a more international presence allows us to connect more effectively with our global clientele and partners.
Connect with Us and Accessing Insightful Resources
Porton's website now offers a library of practical case studies, whitepapers, newsletter and industry insights to invite collaboration with our customers, and illustrating how we overcome technical challenges with our advanced technological solutions. Engage with us to understand how we can cater to your specific needs and project requirements.
We warmly invite you to explore the innovative changes on www.portonpharma.com,
and discover how our new reach and fresh content can empower your business to
achieve new heights.
Others
More
News 2025-01-14
Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
Recently, the Porton Biologics and Conjugates Platform successfully completed the GMP contract manufacturing of three batches of sterile drug products for a client at our R&D and production facility in Pudong, Shanghai. This milestone marks a significant step forward for our Biologics and Conjugates CDMO platform—a testament to our unwavering commitment to quality and reliability.
News 2025-01-03
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that it scored 44 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment reflecting an improvement of 6 points over the previous assessment, where scores in all the three dimensions getting improved. (CSA Score as of 27/11/2024).
